Advertisement
Advertisement

TARA

TARA logo

Protara Therapeutics, Inc. Common Stock

6.66
USD
Sponsored
+0.16
+2.46%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

6.63

-0.03
-0.38%

TARA Earnings Reports

Positive Surprise Ratio

TARA beat 27 of 40 last estimates.

68%

Next Report

Date of Next Report
Mar 03, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.33
Implied change from Q3 25 (Revenue/ EPS)
--
/
+6.45%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-32.65%

Protara Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, TARA reported earnings of -0.31 USD per share (EPS) for Q3 25, beating the estimate of -0.39 USD, resulting in a 20.86% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.33 USD, with revenue projected to reach -- USD, implying an increase of 6.45% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Protara Therapeutics, Inc. Common Stock reported EPS of -$0.31, beating estimates by 20.86%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.59%, changed from $4.29 before the earnings release to $4.53 the day after.
The next earning report is scheduled for Mar 03, 2026.
Based on 7 analysts, Protara Therapeutics, Inc. Common Stock is expected to report EPS of -$0.33 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement